Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta

Biomaterials

Volumn 27, Issue 28, 2006, Pages 4955-4962

  Peuster, Matthias ^a   Hesse, Carola ^a   Schloo, Tirza ^a   Fink, Christoph ^b   Beerbaum, Philipp ^a   von Schnakenburg, Christian ^c  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b German Pediatric Heart Center   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Biodegradation; Corrosion; Degradation; Intimal hyperplasia; Stent

Indexed keywords

ANGIOGRAPHY; BIODEGRADATION; BIODIVERSITY; BIOLOGICAL ORGANS; CORROSION; DISEASES; IRON; NEUROLOGY; TOXICITY;

HEART DEFECTS; INTIMAL HYPERPLASIA; PORCINE; STENTS;

BIOCOMPATIBILITY;

IRON;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CHEMICAL COMPOSITION; COMMERCIAL PHENOMENA; CONTROLLED STUDY; CORROSION; DESCENDING AORTA; FOLLOW UP; HEART; HISTOPATHOLOGY; IRON OVERLOAD; KIDNEY; LIVER; LUNG; MALE; MINIPIG; MORPHOMETRICS; MUSCLE STRETCHING; NONHUMAN; PARAAORTIC LYMPH NODE; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPETITIVE STRAIN INJURY; RISK ASSESSMENT; SPLEEN; STENT; SYSTEMIC DISEASE; TUBE;

ANIMALS; AORTA, THORACIC; BLOOD VESSEL PROSTHESIS IMPLANTATION; BLOOD VESSELS; IRON; MALE; MATERIALS TESTING; STENTS; SWINE; SWINE, MINIATURE; TISSUE DISTRIBUTION;

ANIMALIA; SUIDAE;

EID: 33744988409     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.05.029     Document Type: Article

References (42)

1. Dotter C.T. Transluminally placed coilspring endarterial tube grafts. Long-term patency in canine popliteal artery. Invest Radiol 4 (1969) 329-332
2. Sigwart U., Puel J., Mirkovitch V., Joffre F., and Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316 (1987) 701-706
3. Mullins C.E., O'Laughlin M.P., Vick III G.W., Mayer D.C., Myers T.J., Kearney D.L., et al. Implantation of balloon-expandable intravascular grafts by catheterization in pulmonary arteries and systemic veins. Circulation 77 (1988) 188-199
4. O'Laughlin M.P., Perry S.B., Lock J.E., and Mullins C.E. Use of endovascular stents in congenital heart disease. Circulation 83 (1991) 1923-1939
5. Okubo M., and Benson L.N. Intravascular and intracardiac stents used in congenital heart disease. Curr Opin Cardiol 16 (2001) 84-91
6. Rutanen J., Puhakka H., and Yla-Herttuala S. Post-intervention vessel remodeling. Gene Ther 9 (2002) 1487-1491
7. McMahon C.J., El-Said H.G., Grifka R.G., Fraley J.K., Nihill M.R., and Mullins C.E. Redilation of endovascular stents in congenital heart disease: factors implicated in the development of restenosis and neointimal proliferation. J Am Coll Cardiol 38 (2001) 521-526
8. Donath K., and Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues. The Sage-Schliff (sawing and grinding) technique. J Oral Pathol 11 (1982) 318-326
9. Weaker F.J., and Richardson L. Staining calcified tissues in plastic embedding medium. Am J Med Technol 45 (1979) 363-365
10. Stack R.S., Califf R.M., Phillips H.R., Pryor D.B., Quigley P.J., Bauman R.P., et al. Interventional cardiac catheterization at Duke Medical Center. Am J Cardiol 62 (1988) 3F-24F
11. Susawa T., Shiraki K., and Shimizu Y. Biodegradable intracoronary stents in adult dogs. J Am Coll Cardiol 21 (1993) 483A
12. van der Giessen W.J., Lincoff A.M., Schwartz R.S., van Beusekom H.M., Serruys P.W., Holmes Jr. D.R., et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94 (1996) 1690-1697
13. Venkatraman S., Poh T.L., Vinalia T., Mak K.H., and Boey F. Collapse pressures of biodegradable stents. Biomaterials 24 (2003) 2105-2111
14. Tamai H., Igaki K., Kyo E., Kosuga K., Kawashima A., Matsui S., et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 102 (2000) 399-404
15. Olmedo D., Fernandez M.M., Guglielmotti M.B., and Cabrini R.L. Macrophages related to dental implant failure. Implant Dent 12 (2003) 75-80
16. Reclaru L., Lerf R., Eschler P.Y., and Meyer J.M. Corrosion behavior of a welded stainless-steel orthopedic implant. Biomaterials 22 (2001) 269-279
17. Kraft C.N., Diedrich O., Burian B., Schmitt O., and Wimmer M.A. Microvascular response of striated muscle to metal debris. A comparative in vivo study with titanium and stainless steel. J Bone Jt Surg 85 (2003) 133-141
18. Koerten H.K., Onderwater J.J., Koerten E.W., Bernoski F.P., and Nelissen R.G. Observations at the articular surface of hip prostheses: an analytical electron microscopy study on wear and corrosion. J Biomed Mater Res 54 (2001) 591-596
19. Koster R., Vieluf D., Kiehn M., Sommerauer M., Kahler J., Baldus S., et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 356 (2000) 1895-1897
20. Ryan M.P., Williams D.E., Chater R.J., Hutton B.M., and McPhail D.S. Why stainless steel corrodes. Nature 415 (2002) 770-774
21. Ries M.W., Kampmann C., Rupprecht H.J., Hintereder G., Hafner G., and Meyer J. Nickel release after implantation of the Amplatzer occluder. Am Heart J 145 (2003) 737-741
22. Heintz C., Riepe G., Birken L., Kaiser E., Chakfe N., Morlock M., et al. Corroded nitinol wires in explanted aortic endografts: an important mechanism of failure?. J Endovasc Ther 8 (2001) 248-253
23. Peuster M., Fink C., von Schnakenburg C., and Hausdorf G. Dissolving tungsten coils lack systemic toxicity but lead to elevated serum tungsten levels and recanalization of the previously occluded vessel. Cardiol Young 12 (2002) 229-235
24. Peuster M., Fink C., Wohlsein P., Bruegmann M., Guenther A., Kaese V., et al. Degradation of tungsten coils implanted into the subclavian artery of New Zealand white rabbits is not associated with local or systemic toxicity. Biomaterials 24 (2003) 393-399
25. Peuster M., Wohlsein P., Brügmann M., Ehlerding M., Seidler K., Fink C., et al. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal. results 6-18 months after implantation into New Zealand white rabbits. Heart 86 (2001) 563-569
26. Koster R., Vieluf D., Kiehn M., Sommerauer M., Kahler J., Baldus S., et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 356 (2000) 1895-1897
27. Heintz C., Riepe G., Birken L., Kaiser E., Chakfe N., Morlock M., et al. Corroded nitinol wires in explanted aortic endografts: an important mechanism of failure?. J Endovasc Ther 8 (2001) 248-253
28. Heublein B., Rohde R., Kaese V., Niemeyer M., Hartung W., and Haverich A. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?. Heart 89 (2003) 651-656
29. Peeters P., Bosiers M., Verbist J., Deloose K., and Heublein B. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia. J Endovasc Ther 12 (2005) 1-5
30. Di Mario C., Griffiths H., Goktekin O., Peeters N., Verbist J., Bosiers M., et al. Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol 17 (2004) 391-395
31. Van Belle E., Tio F.O., Couffinhal T., Maillard L., Passeri J., and Isner J.M. Stent endothelialization. time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation 95 (1997) 438-448
32. Bauerschmidt P., and Schaldach M. The electrochemical aspects of the thrombogenicity of a material. J Bioeng 1 (1977) 261-278
33. Sprague E.A., Luo J., and Palmaz J.C. Endothelial cell migration onto metal stent surfaces under static and flow conditions. J Long Term Eff Med Implants 10 (2000) 97-110
34. Grewe P.H., Deneke T., Machraoui A., Barmeyer J., and Mueller K.M. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. JACC 35 (2000) 157-163
35. Gaspardone A., and Versaci F. Coronary stenting and inflammation. Am J Cardiol 96 Suppl. (2005) 65L-70L
36. Santin M., Mikhalovska L., Lloyd A.W., Mikhalovsky S., Sigfrid L., Denyer S.P., et al. In vitro host response assessment of biomaterials for cardiovascular stent manufacture. J Mater Sci Mater Med 15 (2004) 473-477
37. Sullivan T.M., Ainsworth S.D., Langan E.M., Taylor S., Snyder B., Cull D., et al. Effect of endovascular stent strut geometry on vascular injury, myointimal hyperplasia, and restenosis. J Vasc Surg 36 (2002) 143-149
38. Farb A., Weber D.K., Kolodgie F.D., Burke A.P., and Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 105 (2002) 2974-2980
39. Schulz C., Herrmann R.A., Beilharz C., Pasquantonio J., and Alt E. Coronary stent symmetry and vascular injury determine experimental restenosis. Heart 83 (2000) 462-467
40. Sigler M., Schneider K., Meissler M., Koenig K., and Schneider M.B. Breakable stent for interventions in infants and neonates. An animal study and histopathological findings. Heart 92 (2006) 245-248
41. Andrews N.C. Molecular control of iron metabolism. Best Pract Res Clin Haematol 18 (2005) 159-169
42. Heeney M.M., and Andrews N.C. Iron homeostasis and inherited iron overload disorders: an overview. Hematol Oncol Clin North Am 18 (2004) 1379-1403